Jubilant Ingrevia Ltd
Jubilant Ingrevia Ltd (JUBLINGREA)

Jubilant Ingrevia Ltd (JUBLINGREA)


Key Stats

Day's Price Range
52-Week Price Range
1 Month Return7.58 %
3 Month Return4.29 %
1 Year Return-33.89 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

Rank 141
Rank 84
Rank 105
Dividend Yield
Rank 170
Rank 64
Price To Book Ratio
Rank 165
Debt To Asset
Rank 185

Company Information

Jubilant Ingrevia Limited is one of the flagship companies representing life science products and services. The Company was incorporated as a Public Limited Company on 23 October 2019 under provisions of Companies Act 2013 in Uttar Pradesh. The name of Company was changed from Jubilant LSI Limited to Jubilant Ingrevia Limited vide Certificate of Incorporation effective from 16 October 2020. Jubilant Ingrevia Limited is a part of the Jubilant Bhartia Group a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today the Group has a strong presence in diverse sectors like Pharmaceuticals Contract Research and Development Services Proprietary Novel Drugs Life Science Ingredients Agri Products Performance Polymers Food Service QSR Food Auto Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges Jubilant Ingrevia Limited Jubilant Pharmova Limited Jubilant FoodWorks Limited and Jubilant Industries Limited. The Companys stateoftheart manufacturing facilities across India offer a range of products and solutions that are innovative costeffective and quality driven. The Company established itself as a single point solution for CDMO services for global Pharmaceutical andAgrochemical companies. The Company is at present across the value chain: Route design Process Development Process Optimisation Scaleup and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. Its strong synthetic organic chemistry and manufacturing capabilities makes the Partner of Choice for its customers. The Company is a leading supplier of Ethanol to Oil Marketing Companies OMCs for Ethanol Blending Programme EBP among standalone distilleries in India. At present the Company is venturing into o Extra Neutral Alcohol ENA facility to cater to Indian distilleries markets.The Company is a global integrated life science products and innovative solutions provider serving pharmaceutical nutrition agrochemical consumer and industrial customers with its customised products and solutions that are innovative cost effective and conforming to premium quality standards. The Company is engaged in manufacturing and supply of speciality intermediates nutrition health solutions and life science chemicals through five manufacturing facilities in India. The Company offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The business focuses on three core segments Speciality Chemicals Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3 Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of VitaminB3 and Indias largest manufacturer of Vitamin B4. The Company is a Partner of Choice for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand Phytoshield. The Board of Directors of Company in their meeting held on 24 October 2019 had approved the Composite Scheme of Arrangement for amalgamation of certain promoter controlled entities into Jubilant Pharmova Limited JPM the Demerged Company and demerger of Life Science Ingredients business into the Company which was subsequently filed with National Company Law Tribunal NCLT. The Composite Scheme was approved by Honourable NCLT Allahabad Bench vide its Order dated 23 December 2020. The Said NCLT Order was filed with the Registrar of Companies ROC by the Company and the Demerged Company on 01 February 2021 thereby making Composite Scheme effective. In terms of Composite Scheme all assets and liabilities of LSI business of the Demerged Company were transferred and vested into the Company on 1 February 2021 being the Demerger Appointed Date.
OrganisationJubilant Ingrevia Ltd